Community acquired methicillin-resistant staphylococcus aureus

  • Matejka Bremec
  • Marija Gubina
Keywords: CA-MRSA, chromosomal cassette, PVL, β-lactam antibiotics, MW2

Abstract

Background: The article presents the increase in risk of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection among sportsmen, newborn infants and children because of its successful reproduction and existence of new strains. The clinical cases, also in Slovenia, have warned about the presence and development of the pathogen in the community. Different routes of infection, their appearance means of spread and prevention are emphasized. The infection is dangerous, and can be fatal, when the bacteria contains the Panton-Valentine leukocidin (PVL) gene. Because fast spreading of infection is possible, the early diagnosis and subsequent treatment is important.

Conclusions: As the consequences of the staphylococcal infection can be very serious and also life-threatening, one must have in mind a possibility of a CA-MRSA infection. In such case, we have to take measures of correct diagnosis, treatment and limitation of the spread of infection from the infected to the healthy person.

Downloads

Download data is not yet available.

References

Seme K. Stafilokoki. In: Gubina M, Ihan A. Medicinska bakteriologija z imunologijo in mikologijo. Ljubljana: Medicinski razgledi; 2002. p. 139–45.

Lindsay JA, Holden MTG. Staphylococcus aureus: superbug, super genome? Trends Microbiol 2004; 12: 378–5.

Wertheim HFI, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infection. Lancet Infect Dis 2005; 5: 751–62.

Regev-Yochay G, Rubinstein E, Barzilai A, Carmeli Y, Kuint J, Etienne J, et al. Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg Infect Dis 2005; 3: 453–6.

EARSS. Annual report 2004. Dosegljivo na: www.rivm.nl

EARSS. Annual report 2001. Dosegljivo na: www.rivm.nl

Gubina M. Mikrobiologov pogled na akutno in kronično rano. In: Smrke D, ed. Sodobni pristopi k zdravljenju akutne in kronične rane. Simpozij o ranah z mednarodno udeležbo; 2006, Jun 2-3; Portorož, Slovenija. Ljubljana: Klinični oddelek za kirurške infekcije, Kirurška klinika, Klinični center, 2006.

Said-Salim B, Mathema B, Kreiswirth BN. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 2003; 6: 451–5.

Richet HM, Benbachir M, Brown DFJ, Giamarellou H, Gould I, Gubina M, et al. Are there regional variation in the diagnosis, surveillance, and control of methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2003; 24: 1–8.

Shukla SK. Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence. Clin Medic & Rese- Arch 2005; 2: 57–60.

Center for disease control and prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus. Minnesota and North Dakota, 1997–1999. MMWR 1999; 48: 707–10.

Muller-Premru M, Strommenger B, Alikadic N, Witte W, Friedrich AW, Seme K, et al. New strains of community-acquired methicillin- resistant Staphylococcus aureus with Panton-Valentine leukocidin causing an outbreak of severe soft tissue infection in football team. Eur J Clin Microbiol Infect Dis 2005; 24: 848–50.

Romano R, Lu D, Holtom P. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infection among a collegiate football team. J Athl Train 2006; 41: 141–5.

Ochoa TJ, Mohr J, Wanger A, Murphy JR, Heresi GP. Community- associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerg Infect Dis 2005; 6: 966–8.

Chavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, et al. Inducible clindamicin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin- resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother 2005; 6: 2283–8.

Frey PD, Said-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, Davis CC, et al. Comparative molecular analysis of community- or hospital- acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 1: 196–203.

Bratu S, Eramo A, Kopec R, Coughlin E, Ghitan M, Yost R, et al. Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis 2005; 6: 808–13.

Saiman L, O’Keefe M, Graham PL, Wu F, Said-Salim B, Kreiwirth B, et al. Hospital transmission of community-acquired methicillin- resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003; 37: 1313–9.

Grmek-Košnik I, Dermota U, Juteršek B. Proti meticilinu odporna bakterija Staphylococcus aureus domačega okolja. Zdrav Vestn 2005; 74: 159–65.

How to Cite
1.
Bremec M, Gubina M. Community acquired methicillin-resistant staphylococcus aureus. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];76(4). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/1693
Section
Review article

Most read articles by the same author(s)